ReviewBiochemical Society transactions2026
Emerging roles of pterins as signaling molecules in bacteria.
Review in Biochemical Society transactions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Pterins are redox-active biomolecules with well-established functions as enzymatic cofactors in all domains of life. Examples of pterin cofactors include tetrahydrofolate, an essential carrier of one-carbon units, and the molybdenum cofactor (Moco)-composed of molybdopterin bound to molybdenum or tungsten-which supports a wide range of redox reactions for diverse enzymes. Pterins also play important roles outside of enzyme active sites where they serve as antioxidants and immune system modulators. Recently, a new role for pterins in bacteria has emerged through the discovery of a pterin-dependent regulator called DcpA that modulates the cytoplasmic second messenger cyclic-di-guanylate monophosphate (c-di-GMP) levels and biofilm formation in Agrobacterium tumefaciens, a model bacterial plant pathogen. The regulatory pathway involves the PruA pteridine reductase and a periplasmic pterin-binding protein termed PruR. This review provides an overview of each of the key players in this pathway and highlights the broad distribution of the respective genes that supports the presence of similar pterin-mediated regulatory pathways in diverse bacteria. In our current model for the A. tumefaciens pathway, PruA generates a tetrahydropterin species that is released to the periplasm where it binds to PruR. The pterin-PruR complex then interacts with the periplasmic domain of DcpA to promote c-di-GMP degradation. The decreased levels of cytoplasmic c-di-GMP disfavor attachment and limit biofilm formation. The redox active nature of pterins is likely a central facet of their signaling functions, where the different redox states of a given pterin species may reflect changing environmental conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.